Factor V Leiden Genotype
The Factor V Leiden genotype is a genetic variant that increases the risk of developing blood clots due to activated protein C resistance.
Factor V Leiden genotype predicts increased risk of thrombophilia.
Key facts at a glance
- Units
- genotype
- Clinical utility
- predictive
- Result kind
- qualitative
- FDA-cleared
- Roche Factor V Leiden PCR, Cepheid Factor V Leiden
Factor V Leiden is a genetic mutation that affects the blood clotting process by making the body resistant to activated protein C, a natural anticoagulant.
Individuals with this genotype have a higher risk of developing venous thromboembolism, especially in situations such as pregnancy, surgery, or prolonged immobility.
Testing for Factor V Leiden is important for identifying individuals who may benefit from preventive measures or altered treatment plans to reduce clotting risk.
Frequently asked questions
What is the significance of a positive Factor V Leiden test?
Should all individuals be tested for Factor V Leiden?
Sources
- 1
- 2Factor V Leiden MutationSource
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy